High levels of the human carcinogen benzene can form in some acne treatment products containing benzoyl peroxide, according to a new report from the independent quality assurance laboratory Valisure. The company has launched a citizen petition urging FDA to take action on these products by encouraging an investigation and market withdrawal of the affected items.

FDA announced the decision to approve the GLP-1 receptor agonist, semaglutide (Wegovy), to reduce the risk of CV death, heart attack, and stroke in adults with CVD and obesity or overweight.

FDA’s Vaccines and Related Biological Products Advisory Committee recommended that regulators drop the quadrivalent influenza vaccines used for roughly the past decade or so in favor of a trivalent replacement.